Stonegate Investment Group, LLC Edwards Lifesciences Corp Transaction History

Stonegate Investment Group, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 02, 2024	SELL	$84.3 - $94.31 $4,215 - $4,715	-50 Reduced 0.34%	14,714 $1.36 Million
Q1 2024 Apr 22, 2024	BUY	$72.54 - $95.56 $139,276 - $183,475	1,920 Added 14.95%	14,764 $1.41 Million
Q4 2023 Jan 23, 2024	SELL	$61.71 - $77.76 $3,332 - $4,199	-54 Reduced 0.42%	12,844 $979,000
Q3 2023 Oct 24, 2023	SELL	$69.28 - $93.38 $15,241 - $20,543	-220 Reduced 1.68%	12,898 $893,000
Q1 2023 Apr 20, 2023	BUY	$74.26 - $84.51 $177,629 - $202,147	2,392 Added 22.3%	13,118 $1.09 Million
Q4 2022 Jan 24, 2023	SELL	$68.3 - $87.44 $3,824 - $4,896	-56 Reduced 0.52%	10,726 $0
Q3 2022 Oct 28, 2022	SELL	$82.37 - $107.29 $263,831 - $343,649	-3,203 Reduced 22.9%	10,782 $891,000
Q2 2022 Aug 09, 2022	SELL	$86.5 - $128.27 $342,107 - $507,307	-3,955 Reduced 22.05%	13,985 $1.33 Million
Q1 2022 May 16, 2022	BUY	$101.96 - $128.34 $46,085 - $58,009	452 Added 2.58%	17,940 $2.11 Million
Q4 2021 Feb 11, 2022	BUY	$106.37 - $130.68 $1.86 Million - $2.29 Million	17,488 New	17,488 $2.27 Million

1,362

467M

9.76M

3.89M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $44.1B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Stonegate Investment Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Stonegate Investment Group, LLC with notifications on news.